Metformin, a biguanide anti-hyperglycemic agent, activates adenosine monophosphate-activated protein kinase, a cellular metabolic regulator, by upregulating Bmal1 expression in T2D mice (Alex et al., 2020). This evidence concerns the gene BMAL1 and type 2 diabetes mellitus.